An analysis of blinding success in a randomised controlled trial of fish oil omega-3 fatty acids

Jean C.J. Liu, Adrian Raine, Rebecca P. Ang, Daniel S.S. Fung

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

INTRODUCTION: Incidental reports collected in clinical trials suggest that amongst participants, omega-3 fatty acids derived from fish oil ('omega-3') may be difficult to blind.

MATERIALS AND METHODS: We conducted a systematic evaluation of blinding success in a 24-week trial of omega-3 versus an oil-based placebo. Within 1 week of supplement commencement (Week 1), a blinding questionnaire was completed by 131 children enrolled in a trial of omega-3 for the treatment of disruptive behaviour disorders. A version of the questionnaire was also completed by their parents at Week 1, and by the children at the end of supplement administration (Week 24).

RESULTS: Participants were unable to differentiate omega-3 from placebo, and accuracy did not improve as a function of: the confidence of guesses, reason for guesses, notice of any change, beliefs about what should change, or time. Child and parent guesses also showed high concordance.

CONCLUSION: Taken together, these data provide strong evidence that the identity of omega-3 can be blinded to participants.

Original languageEnglish
Pages (from-to)85-91
Number of pages7
JournalAnnals of the Academy of Medicine, Singapore
Volume44
Issue number3
Publication statusPublished - Mar 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Fingerprint

Dive into the research topics of 'An analysis of blinding success in a randomised controlled trial of fish oil omega-3 fatty acids'. Together they form a unique fingerprint.

Cite this